Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 27, 2014	Sep. 27, 2014	Jun. 28, 2014	Mar. 29, 2014	Dec. 28, 2013	Sep. 28, 2013	Jun. 29, 2013	Mar. 30, 2013	Dec. 27, 2014		Dec. 28, 2013		Dec. 29, 2012
Net sales	$ 679.9	$ 588.7	$ 674.3	$ 663.2	$ 717.1	$ 603.2	$ 688.4	$ 662.9	$ 2,606.1		$ 2,671.6		$ 2,583.8
Cost of products sold									884.0		889.8		856.4
Gross margin	452.4	379.5	448.6	441.6	475.7	403.6	462.4	440.1	1,722.1		1,781.8		1,727.4
Delivery, sales and administrative expense									1,346.1		1,369.7		1,329.5
Re-engineering and impairment charges	2.7	2.6	3.4	2.3	2.2	2.7	2.2	2.2	11.0	[1]	9.3	[1]	22.4	[1]
Impairment of goodwill and intangible assets									0	[2]	0	[2]	76.9	[2]
Gains on disposal of assets									2.7		0.7		7.9
Operating income									367.7		403.5		306.5
Interest income									3.0		2.6		2.5
Interest expense									46.5		40.2		34.9
Other expense									26.0		5.5		1.3
Income before income taxes									298.2		360.4		272.8
Provision for income taxes									83.8		86.2		79.8
Net income	$ 82.3	$ 32.3	$ 47.6	$ 52.2	$ 89.8	$ 49.9	$ 76.3	$ 58.2	$ 214.4		$ 274.2		$ 193.0
Earnings Per Share [Abstract]
Basic earnings per common share	$ 1.65	$ 0.64	$ 0.95	$ 1.04	$ 1.78	$ 0.97	$ 1.46	$ 1.09	$ 4.28		$ 5.28		$ 3.49
Diluted earnings per common share	$ 1.63	$ 0.63	$ 0.93	$ 1.02	$ 1.74	$ 0.95	$ 1.43	$ 1.06	$ 4.20		$ 5.17		$ 3.42

[1] The re-engineering and impairment charges line includes severance expenses and other exit costs. See Note 2 to the Consolidated Financial Statements.

[2] Reviews of the value of the intangible assets related to the acquisition of the Sara Lee direct-to-consumer units acquired in 2005 and BeautiControl acquired in 2000, resulted in the conclusion that certain of the tradenames and goodwill had been impaired in 2012. This resulted in charges of $76.9 million related to BeautiControl, NaturCare and Nutrimetics. There were no such impairments in 2013 and 2014. See Note 6 for further details.